Prescribing for Diabetes in England: Supplement – January 2002 to March 2009
The number of prescription items and Net Ingredient Cost (NIC) are used to analyse volume, expenditure and trends in the prescribing of insulin and anti-diabetic drugs (NHS Information Centre)
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
In patients with poorly controlled T1DM, at similar glycaemic levels, adjunct metformin therapy during 1 year significantly lowered levels of proatherogenic cholesterolaemia independent of statin therapy (Diabetes, Obesity and Metabolism)
Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
Intensive glucose control reduced the risk for some cardiovascular disease outcomes (such as nonfatal myocardial infarction), did not reduce the risk for cardiovascular death or all-cause mortality, and increased the risk for severe hypoglycemia (Annals of Internal Medicine)
Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes
In patients with recent-onset type 2 diabetes, treatment with insulin or metformin compared with placebo did not reduce inflammatory biomarker levels despite improving glucose control (JAMA)
Role of Renin-Angiotensin System Blockade in Patients With Diabetes Mellitus
Overwhelming evidence suggests that the RAS plays an important role in the pathogenesis of DM and its associated cardiovascular risks (American Journal of Cardiology)
Inspiring New Online Destination From Bayer Diabetes Care
Bayer Diabetes Care is continuing to simplify life for people with diabetes with the launch of simplewins.com, an online destination designed to inspire people with diabetes and help them meet the day-to-day challenges of living with and managing the disease (PharmaLive)
Diabetes centre honours pioneer
A new centre for diabetes patients, named after one of Scotland’s leading experts on the condition, has opened in Lanarkshire (BBC, UK)
Effectiveness of Cinnamon for Lowering Hemoglobin A1C in Patients with Type 2 Diabetes: A Randomized, Controlled Trial
Taking cinnamon could be useful for lowering serum HbA1C in type 2 diabetics with HbA1C >7.0 in addition to usual care (Journal of the American Board of Family Medicine)
Glycosmedia is also available as an App: